Discounted Cash Flow
Teladoc Health, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $123.2m | $-74.2m | $-54.0m | -60.3% | — |
| 2017 | $233.3m (89.4%) | $-106.8m (-43.9%) | $-37.1m (31.3%) | -45.8% (24.0%) | — |
| 2018 | $417.9m (79.1%) | $-97.1m (9.1%) | $-8.9m (76.1%) | -23.2% (49.2%) | — |
| 2019 | $553.3m (32.4%) | $-98.9m (-1.8%) | $26.4m (397.1%) | -17.9% (23.1%) | $-1.38 |
| 2020 | $1.1b (97.7%) | $-485.1m (-390.7%) | $-57.5m (-318.3%) | -44.3% (-148.2%) | $-5.36 (-288.4%) |
| 2021 | $2.0b (85.8%) | $-428.8m (11.6%) | $185.5m (422.3%) | -21.1% (52.4%) | $-2.73 (49.1%) |
| 2022 | $2.4b (18.4%) | $-13.7b (-3085.6%) | $172.8m (-6.8%) | -567.5% (-2590.4%) | $-84.60 (-2998.9%) |
| 2023 | $2.6b (8.1%) | $-220.4m (98.4%) | $338.6m (95.9%) | -8.5% (98.5%) | $-1.34 (98.4%) |
| 2024 | $2.6b (-1.3%) | $-1.0b (-354.4%) | $282.9m (-16.4%) | -39.0% (-360.2%) | $-5.87 (-338.1%) |
| 2025 | $2.5b (-1.5%) | $-200.3m (80.0%) | $285.5m (0.9%) | -7.9% (79.7%) | $-1.14 (80.6%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.